Back
Regeneron Pharmaceuticals Stock Price Chart

Former Zillow exec targets $1.3T marke
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa
Sell
37
REGN
Regeneron Pharmaceuticals
Last Price:
$509.69
Seasonality Move:
9.62%
7 Day Trial
ALL ACCESS PASS
$
7

The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com. Reserving the ticker symbol is not a guarantee that the compa-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing slight buying pressure.
Regeneron Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 519.49 | Sell |
20-day SMA: | 533.82 | Sell |
50-day SMA: | 559.47 | Sell |
200-day SMA: | 753.36 | Sell |
8-day EMA: | 517.09 | Sell |
20-day EMA: | 530.41 | Sell |
50-day EMA: | 563.49 | Sell |
200-day EMA: | 708.01 | Sell |
Regeneron Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -16.83 | Sell |
Relative Strength Index (14 RSI): | 42.15 | Sell |
Chaikin Money Flow: | 250436 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (498.89 - 592.19) | Sell |
Bollinger Bands (100): | (548.86 - 683.54) | Sell |
Regeneron Pharmaceuticals Technical Analysis
Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 513.58 while REGN 8-day simple moving average is 519.49, which is a Sell signal.
-
The stock price of REGN is 513.58 while Regeneron Pharmaceuticals 20-day SMA is 533.82, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day simple moving average is 559.47 while REGN share price is 513.58, making it a Sell technically.
-
REGN stock price is 513.58 and Regeneron Pharmaceuticals 200-day simple moving average is 753.36, creating a Sell signal.
REGN Technical Analysis vs Fundamental Analysis
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a SellThe current Regeneron Pharmaceuticals [REGN] share price is $513.58. The Score for REGN is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
55.4B
Price in USD:
513.58
Share Volume:
841.1K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
1,211.20
52-Week Low:
476.49
Sell
37
Regeneron Pharmaceuticals (REGN)
is a Sell
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?The Regeneron Pharmaceuticals stock price is 513.58 USD today.
-
Will REGN stock go up or go down?Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Regeneron Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
-
Regeneron Pharmaceuticals share price is 513.58 while REGN 8-day exponential moving average is 517.09, which is a Sell signal.
-
The stock price of REGN is 513.58 while Regeneron Pharmaceuticals 20-day EMA is 530.41, which makes it a Sell.
-
Regeneron Pharmaceuticals 50-day exponential moving average is 563.49 while REGN share price is 513.58, making it a Sell technically.
-
REGN stock price is 513.58 and Regeneron Pharmaceuticals 200-day simple moving average is 708.01, creating a Sell signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
-
Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.72 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
-
REGN Moving Average Covergence Divergence (MACD) indicator is -16.83, suggesting Regeneron Pharmaceuticals is a Sell
-
Regeneron Pharmaceuticals Relative Strength Index (RSI) is 42.15, which suggest Regeneron Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Regeneron Pharmaceuticals is (498.89 - 592.19), which suggest Regeneron Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Regeneron Pharmaceuticals is (548.86 - 683.54), which suggest Regeneron Pharmaceuticals is a Sell
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.